Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.37 |
| ▸ | GUSB | P08236 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18605543 | 1.00 | CYP4F2 (0.40) | CYP4F2CYP4A11HSP90AB1POLBKMT2A | |
| SCHEMBL28759020 | 0.83 | CYP4F2 (0.43) | CYP4F2CYP4A11HSP90AB1POLBKMT2A | |
| SCHEMBL3730288 | 0.83 | NOTUM (0.49) | CYP4F2CYP4A11POLBKMT2AHTT | |
| SCHEMBL274593 | 0.83 | FOLH1 (0.52) | CYP4F2CYP4A11FOLH1 | |
| SCHEMBL4675850 | 0.81 | CYP4F2 (0.43) | CYP4F2CYP4A11HSP90AB1POLBKMT2A | |
| SCHEMBL2628186 | 0.81 | CYP4F2 (0.40) | CYP4F2CYP4A11HSP90AB1POLBKMT2A | |
| SCHEMBL21063617 | 0.81 | MAOA (0.47) | CYP4F2CYP4A11POLBKMT2AHTT | |
| SCHEMBL15199191 | 0.81 | MAOB (0.43) | CYP4F2CYP4A11HSP90AB1POLBKMT2A | |
| SCHEMBL23038420 | 0.80 | POLB (0.57) | CYP4F2CYP4A11POLBKMT2A | |
| SCHEMBL19296368 | 0.80 | LOXL2 (0.37) | POLBKMT2AFOLH1GUSBSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120100073-A1 | PET RADIOTRACERS FOR IMAGING FATTY ACID METABOLISM AND STORAGE | WASHINGTON UNIVERSITY (US) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120100073-A1 | PET RADIOTRACERS FOR IMAGING FATTY ACID METABOLISM AND STORAGE | LIPC, PNLIP, FFAR1 | CYP4F2 341/4885CYP4A11 1438/4885HSP90AB1 1001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.